申请人:Eli Lilly and Company
公开号:US06359136B1
公开(公告)日:2002-03-19
This application relates to novel compounds of formula I (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula I, and the use of the compounds of formula I as thrombin inhibitors.
本申请涉及公式I的新化合物(及其药学上可接受的盐),如本文所定义的,用于制备这些化合物的过程和中间体,包含这些新化合物的药物配方,以及将公式I的化合物用作凝血酶抑制剂的用途。